摘要
目的探讨载脂蛋白(apolipoprotein,apo)C1基因(APOC1)rs4420638A/G和-317H1/H2位点多态性与中国妇女子痫前期(pre-eclampsia,PE)发生的相关性及其对临床和代谢指标的影响。方法本研究包括289例PE患者和824例无妊娠并发症的对照孕妇。采用Taqman荧光探针和聚合酶链反应-限制性片段长度多态性方法分别测定APOC1 rs4420638A/G和-317H1/H2位点多态性,采用酶法和PEG增强免疫比浊法分别测定血脂和apo水平。结果APOC1基因rs4420638A/G和-317H1/H2位点基因型频率与等位基因频率在PE组和对照组之间差异无统计学意义(P>0.05)。但是,携带rs4420638位点G等位基因的PE患者有更高的血清甘油三酯、非高密度脂蛋白-胆固醇、apoB水平以及apoB/apoA1比值(P<0.05)。携带-317H1/H2位点H2等位基因的PE患者有更小的分娩孕周(P<0.05)。结论APOC1基因rs4420638和-317H1/H2位点多态性与PE患者血浆脂蛋白代谢异常有关。未发现这两个基因多态性与中国妇女PE发生的风险相关联。
Objective To assess the association of apolipoprotein(apo)C1(APOC1)gene rs4420638A/G and-317H1/H2 polymorphisms with the risk of pre-eclampsia(PE)and the influence of their genotypes on the clinical and metabolic indexes among Chinese women.Methods In total 289 PE patients and 824 women with uncomplicated pregnancies were included.The rs4420638A/G genotype was determined by a Taqman real-time PCR allelic discrimination assay.The-317H1/H2 genotype was measured through PCR and restriction fragment length polymorphism analysis.Serum lipid and apo levels were measured by an enzymatic kit and a PEG-enhanced immunoturbidimetric assay.Results Allelic and genotypic frequencies of the APOC1 gene rs4420638A/G and-317H1/H2 were not significantly different between the two groups(all P>0.05).However,patients carrying the G allele of the rs4420638A/G locus had higher serum levels of triglyceride,non-HDL-C and apoB,and a higher apoB/apoA1 ratio compared with those with an AA genotype(all P<0.05).Patients carrying the H2 allele of the-317H1/H2 polymorphism had smaller delivery gestational weeks compared with those with the H1H1 genotype(P<0.05).Conclusion Polymorphisms of the APOC1 gene rs4420638 and-317H1/H2 sites may be associated with abnormal lipoprotein metabolism among Chinese patients with PE,though no association was found between variants of the APOC1 gene and the risk of PE among them.
作者
孙源
范平
刘青青
白怀
刘兴会
周密
吴玉洁
关林波
李遂焰
Sun Yuan;Fan Ping;Liu Qingqing;Bai Huai;Liu Xinghui;Zhou Mi;Wu Yujie;Guan Linbo;Li Suiyan(School of Life Science and Engineering,Southwest Jiaotong University,Chengdu,Sichuan 610031,China;Laboratory of Genetic Disease and Perinatal Medicine,Key Laboratory of Birth Defects and Related Diseases of Women and Children,Ministry of Education,West China Second Hospital,Sichuan University,Chengdu,Sichuan 610041,China;Department of Obstetrics and Gynecology,West China Second Hospital,Sichuan University,Chengdu,Sichuan 610041,China)
出处
《中华医学遗传学杂志》
CAS
CSCD
2020年第7期774-778,共5页
Chinese Journal of Medical Genetics
基金
四川省科技厅重点研发项目(2019YFS0401)
国家自然科学基金(81471463)。